当前位置: 首页 > 详情页

Risk Factors of Subacute Thrombosis After Intracranial Stenting for Symptomatic Intracranial Arterial Stenosis

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neurol, 6 Tiantan Xili, Beijing 10050, Peoples R China; [2]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [3]China Natl Clin Res Ctr, Neurol Dis Ctr Stroke, Beijing, Peoples R China; [4]Beijing Inst Brain Disorders, Beijing, Peoples R China; [5]Hebei Med Univ, Tangshan Gongren Hosp, Dept Neurol, Shijiazhuang, Peoples R China; [6]Queen Elizabeth Hosp, Dept Med, Hong Kong, Peoples R China
出处:
ISSN:

关键词: aspirin odds ratio perfusion imaging risk factors thrombosis

摘要:
Background and Purpose We aimed to explore the risk factors of subacute thrombosis (SAT) after intracranial stenting for patients with symptomatic intracranial arterial stenosis. Methods From January to December 2013, all symptomatic intracranial arterial stenosis patients who underwent intracranial stenting in Beijing Tiantan Hospital were prospectively registered into this study. Baseline clinical features and operative data were compared in patients who developed SAT with those who did not. Binary logistic regression model was used to determine the risk factors associated with SAT. Results Of the 221 patients enrolled, 9 (4.1%) cases had SAT 2 to 8 days after stenting. Binary logistic analysis showed that SAT was related with tandem stenting (odds ratio [OR], 11.278; 95% confidence interval [CI], 2.422-52.519) and antiplatelet resistance (aspirin resistance: OR, 6.267; 95% CI, 1.574-24.952; clopidogrel resistance: OR, 15.526; 95% CI, 3.105-77.626; aspirin and clopidogrel resistance: OR, 12.246; 95% CI, 2.932-51.147; and aspirin or clopidogrel resistance: OR, 11.340; 95% CI, 2.282-56.344). Conclusions Tandem stenting and antiplatelet resistance might contribute to the development of SAT after intracranial stenting in patients with symptomatic intracranial arterial stenosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 外周血管病
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学 1 区 外周血管病
JCR分区:
出版当年[2015]版:
Q1 PERIPHERAL VASCULAR DISEASE Q1 CLINICAL NEUROLOGY
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q1 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neurol, 6 Tiantan Xili, Beijing 10050, Peoples R China; [2]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [3]China Natl Clin Res Ctr, Neurol Dis Ctr Stroke, Beijing, Peoples R China; [4]Beijing Inst Brain Disorders, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neurol, 6 Tiantan Xili, Beijing 10050, Peoples R China; [2]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [3]China Natl Clin Res Ctr, Neurol Dis Ctr Stroke, Beijing, Peoples R China; [4]Beijing Inst Brain Disorders, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院